title: Is long-term therapy without cyclosporin A (CsA) indispensable or dangerous? One-year results of a prospective randomized trial.
authors.affiliation: Department of Surgery, University of Tübingen, West Germany.
authors.forename: M
authors.initials: M
authors.lastname: Büsing
authors.forename: H
authors.initials: H
authors.lastname: Hölzer
authors.forename: W D
authors.initials: WD
authors.lastname: Schareck
authors.forename: J
authors.initials: J
authors.lastname: Mellert
authors.forename: B
authors.initials: B
authors.lastname: Greger
authors.forename: U T
authors.initials: UT
authors.lastname: Hopt
authors.forename: W
authors.initials: W
authors.lastname: Lauchart
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use*; D002102:Cadaver; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000187:drug effects; D006801:Humans; D016030:Kidney Transplantation; D011239:Prednisolone / Q000627:therapeutic use*; D011446:Prospective Studies; D011897:Random Allocation
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D011239:Prednisolone; D001379:Azathioprine